Repligen Q2 2024 Adj. EPS $0.33, Inline, Sales $154.073M Miss $154.121M Estimate
Portfolio Pulse from Benzinga Newsdesk
Repligen reported Q2 2024 adjusted EPS of $0.33, which was in line with expectations. However, the company missed its sales estimate, reporting $154.073 million compared to the expected $154.121 million.
July 30, 2024 | 11:32 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Repligen's Q2 2024 adjusted EPS met expectations at $0.33, but the company slightly missed its sales estimate, reporting $154.073 million compared to the expected $154.121 million.
The in-line EPS suggests stable profitability, but the slight miss in sales could indicate minor concerns about revenue growth. The overall impact on the stock price is likely to be neutral in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100